Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 355

1.

Weight calibration to improve the efficiency of pure risk estimates from case-control samples nested in a cohort.

Shin YE, Pfeiffer RM, Graubard BI, Gail MH.

Biometrics. 2019 Dec 21. doi: 10.1111/biom.13209. [Epub ahead of print]

PMID:
31863593
2.

The Need for Combined Assessment of Multiple Outcomes in Noninferiority Trials in Oncology.

Jatoi I, Gail MH.

JAMA Oncol. 2019 Dec 12. doi: 10.1001/jamaoncol.2019.5361. [Epub ahead of print]

PMID:
31830235
3.

Design choices for observational studies of the effect of exposure on disease incidence.

Gail MH, Altman DG, Cadarette SM, Collins G, Evans SJ, Sekula P, Williamson E, Woodward M.

BMJ Open. 2019 Dec 9;9(12):e031031. doi: 10.1136/bmjopen-2019-031031.

4.

On Mendelian randomization analysis of case-control study.

Zhang H, Qin J, Berndt SI, Albanes D, Deng L, Gail MH, Yu K.

Biometrics. 2019 Oct 18. doi: 10.1111/biom.13166. [Epub ahead of print]

PMID:
31625599
5.

Heart Transplantation From Hepatitis C-Positive Donors in the Era of Direct Acting Antiviral Therapy: A Comprehensive Literature Review.

Bruno S, Nicole B, Nila J D, Gail M, James N, Peter S M, Christopher S H.

Transplant Direct. 2019 Aug 23;5(9):e486. doi: 10.1097/TXD.0000000000000928. eCollection 2019 Sep.

6.

Choosing Breast Cancer Risk Models: Importance of Independent Validation.

Gail MH.

J Natl Cancer Inst. 2019 Sep 26. pii: djz180. doi: 10.1093/jnci/djz180. [Epub ahead of print] No abstract available.

PMID:
31556449
7.

Perspectives for Consideration in the Development of Microbial Cell Reference Materials.

Allen-Vercoe E, Carmical JR, Forry SP, Gail MH, Sinha R.

Cancer Epidemiol Biomarkers Prev. 2019 Dec;28(12):1949-1954. doi: 10.1158/1055-9965.EPI-19-0557. Epub 2019 Sep 12. Review.

PMID:
31515292
8.

Effects of Helicobacter pylori treatment and vitamin and garlic supplementation on gastric cancer incidence and mortality: follow-up of a randomized intervention trial.

Li WQ, Zhang JY, Ma JL, Li ZX, Zhang L, Zhang Y, Guo Y, Zhou T, Li JY, Shen L, Liu WD, Han ZX, Blot WJ, Gail MH, Pan KF, You WC.

BMJ. 2019 Sep 11;366:l5016. doi: 10.1136/bmj.l5016.

9.

Estimating the decision curve and its precision from three study designs.

Pfeiffer RM, Gail MH.

Biom J. 2019 Aug 8. doi: 10.1002/bimj.201800240. [Epub ahead of print]

PMID:
31394013
10.

Comparative validation of breast cancer risk prediction models and projections for future risk stratification.

Choudhury PP, Wilcox AN, Brook MN, Zhang Y, Ahearn T, Orr N, Coulson P, Schoemaker MJ, Jones ME, Gail MH, Swerdlow AJ, Chatterjee N, Garcia-Closas M.

J Natl Cancer Inst. 2019 Jun 4. pii: djz113. doi: 10.1093/jnci/djz113. [Epub ahead of print]

PMID:
31165158
11.

Performance of BCRAT in high-risk patients with breast cancer.

Gail MH.

Lancet Oncol. 2019 Jun;20(6):e285. doi: 10.1016/S1470-2045(19)30301-8. No abstract available.

PMID:
31162092
12.

Mammographic breast density and its association with urinary estrogens and the fecal microbiota in postmenopausal women.

Jones GS, Spencer Feigelson H, Falk RT, Hua X, Ravel J, Yu G, Flores R, Gail MH, Shi J, Xu X, Goedert JJ.

PLoS One. 2019 May 8;14(5):e0216114. doi: 10.1371/journal.pone.0216114. eCollection 2019.

13.

Design and analysis considerations for combining data from multiple biomarker studies.

Sloan A, Song Y, Gail MH, Betensky R, Rosner B, Ziegler RG, Smith-Warner SA, Wang M.

Stat Med. 2019 Apr 15;38(8):1303-1320. doi: 10.1002/sim.8052. Epub 2018 Dec 19.

14.

Next steps in studying the human microbiome and health in prospective studies, Bethesda, MD, May 16-17, 2017.

Sinha R, Ahsan H, Blaser M, Caporaso JG, Carmical JR, Chan AT, Fodor A, Gail MH, Harris CC, Helzlsouer K, Huttenhower C, Knight R, Kong HH, Lai GY, Hutchinson DLS, Le Marchand L, Li H, Orlich MJ, Shi J, Truelove A, Verma M, Vogtmann E, White O, Willett W, Zheng W, Mahabir S, Abnet C.

Microbiome. 2018 Nov 26;6(1):210. doi: 10.1186/s40168-018-0596-z.

15.

Excess Deaths Associated With Underweight, Overweight, and Obesity: An Evaluation of Potential Bias.

Flegal KM, Graubard BI, Williamson DF, Gail MH.

Vital Health Stat 3. 2018 Jun;(42):1-21.

16.

Circulating 25-hydroxyvitamin D up to 3 decades prior to diagnosis in relation to overall and organ-specific cancer survival.

Weinstein SJ, Mondul AM, Yu K, Layne TM, Abnet CC, Freedman ND, Stolzenberg-Solomon RZ, Lim U, Gail MH, Albanes D.

Eur J Epidemiol. 2018 Nov;33(11):1087-1099. doi: 10.1007/s10654-018-0428-2. Epub 2018 Aug 2.

17.

Proportion of U.S. Trends in Breast Cancer Incidence Attributable to Long-term Changes in Risk Factor Distributions.

Pfeiffer RM, Webb-Vargas Y, Wheeler W, Gail MH.

Cancer Epidemiol Biomarkers Prev. 2018 Oct;27(10):1214-1222. doi: 10.1158/1055-9965.EPI-18-0098. Epub 2018 Aug 1.

18.

Circulating Vitamin D and Colorectal Cancer Risk: An International Pooling Project of 17 Cohorts.

McCullough ML, Zoltick ES, Weinstein SJ, Fedirko V, Wang M, Cook NR, Eliassen AH, Zeleniuch-Jacquotte A, Agnoli C, Albanes D, Barnett MJ, Buring JE, Campbell PT, Clendenen TV, Freedman ND, Gapstur SM, Giovannucci EL, Goodman GG, Haiman CA, Ho GYF, Horst RL, Hou T, Huang WY, Jenab M, Jones ME, Joshu CE, Krogh V, Lee IM, Lee JE, Männistö S, Le Marchand L, Mondul AM, Neuhouser ML, Platz EA, Purdue MP, Riboli E, Robsahm TE, Rohan TE, Sasazuki S, Schoemaker MJ, Sieri S, Stampfer MJ, Swerdlow AJ, Thomson CA, Tretli S, Tsugane S, Ursin G, Visvanathan K, White KK, Wu K, Yaun SS, Zhang X, Willett WC, Gail MH, Ziegler RG, Smith-Warner SA.

J Natl Cancer Inst. 2019 Feb 1;111(2):158-169. doi: 10.1093/jnci/djy087.

19.

Using standard microbiome reference groups to simplify beta-diversity analyses and facilitate independent validation.

Maziarz M, Pfeiffer RM, Wan Y, Gail MH.

Bioinformatics. 2018 Oct 1;34(19):3249-3257. doi: 10.1093/bioinformatics/bty297.

20.

Effects of Nutrition Intervention on Total and Cancer Mortality: 25-Year Post-trial Follow-up of the 5.25-Year Linxian Nutrition Intervention Trial.

Wang SM, Taylor PR, Fan JH, Pfeiffer RM, Gail MH, Liang H, Murphy GA, Dawsey SM, Qiao YL, Abnet CC.

J Natl Cancer Inst. 2018 Nov 1;110(11):1229-1238. doi: 10.1093/jnci/djy043.

21.

Breast Cancer Risk Model Requirements for Counseling, Prevention, and Screening.

Gail MH, Pfeiffer RM.

J Natl Cancer Inst. 2018 Sep 1;110(9):994-1002. doi: 10.1093/jnci/djy013.

22.

Design and statistical considerations for studies evaluating the efficacy of a single dose of the human papillomavirus (HPV) vaccine.

Sampson JN, Hildesheim A, Herrero R, Gonzalez P, Kreimer AR, Gail MH.

Contemp Clin Trials. 2018 May;68:35-44. doi: 10.1016/j.cct.2018.02.010. Epub 2018 Feb 21.

23.

Evidence for single-dose protection by the bivalent HPV vaccine-Review of the Costa Rica HPV vaccine trial and future research studies.

Kreimer AR, Herrero R, Sampson JN, Porras C, Lowy DR, Schiller JT, Schiffman M, Rodriguez AC, Chanock S, Jimenez S, Schussler J, Gail MH, Safaeian M, Kemp TJ, Cortes B, Pinto LA, Hildesheim A, Gonzalez P; Costa Rica HPV Vaccine Trial (CVT) Group.

Vaccine. 2018 Aug 6;36(32 Pt A):4774-4782. doi: 10.1016/j.vaccine.2017.12.078. Epub 2018 Feb 1.

24.

Power and sample size for multivariate logistic modeling of unmatched case-control studies.

Gail MH, Haneuse S.

Stat Methods Med Res. 2019 Mar;28(3):822-834. doi: 10.1177/0962280217737157. Epub 2017 Nov 16.

PMID:
29145780
25.

Prenatal diethylstilbestrol exposure and cancer risk in women.

Troisi R, Hatch EE, Titus L, Strohsnitter W, Gail MH, Huo D, Adam E, Robboy SJ, Hyer M, Hoover RN, Palmer JR.

Environ Mol Mutagen. 2019 Jun;60(5):395-403. doi: 10.1002/em.22155. Epub 2017 Nov 10.

PMID:
29124779
26.

Durability of Protection Afforded by Fewer Doses of the HPV16/18 Vaccine: The CVT Trial.

Safaeian M, Sampson JN, Pan Y, Porras C, Kemp TJ, Herrero R, Quint W, van Doorn LJ, Schussler J, Lowy DR, Schiller J, Schiffman MT, Rodriguez AC, Gail MH, Hildesheim A, Gonzalez P, Pinto LA, Kreimer AR; Costa Rica HPV Vaccine Trial (CVT) Group.

J Natl Cancer Inst. 2018 Feb 1;110(2). doi: 10.1093/jnci/djx158.

27.

The prediction impact curve is proportional to the proportion of cases followed (letter commenting: J Clin Epidemiol 2016;69:361-363).

Gail MH.

J Clin Epidemiol. 2017 May;85:70. doi: 10.1016/j.jclinepi.2016.12.020. No abstract available.

PMID:
28645364
28.

The effect of cigarette smoking on the oral and nasal microbiota.

Yu G, Phillips S, Gail MH, Goedert JJ, Humphrys MS, Ravel J, Ren Y, Caporaso NE.

Microbiome. 2017 Jan 17;5(1):3. doi: 10.1186/s40168-016-0226-6.

29.

Association of Estrogen Metabolism with Breast Cancer Risk in Different Cohorts of Postmenopausal Women.

Sampson JN, Falk RT, Schairer C, Moore SC, Fuhrman BJ, Dallal CM, Bauer DC, Dorgan JF, Shu XO, Zheng W, Brinton LA, Gail MH, Ziegler RG, Xu X, Hoover RN, Gierach GL.

Cancer Res. 2017 Feb 15;77(4):918-925. doi: 10.1158/0008-5472.CAN-16-1717. Epub 2016 Dec 23.

30.

Projecting Individualized Absolute Invasive Breast Cancer Risk in US Hispanic Women.

Banegas MP, John EM, Slattery ML, Gomez SL, Yu M, LaCroix AZ, Pee D, Chlebowski RT, Hines LM, Thompson CA, Gail MH.

J Natl Cancer Inst. 2016 Dec 20;109(2). doi: 10.1093/jnci/djw215. Print 2017 Feb.

31.

Comparison of approaches for incorporating new information into existing risk prediction models.

Grill S, Ankerst DP, Gail MH, Chatterjee N, Pfeiffer RM.

Stat Med. 2017 Mar 30;36(7):1134-1156. doi: 10.1002/sim.7190. Epub 2016 Dec 11.

PMID:
27943382
32.

Somatic Genomics and Clinical Features of Lung Adenocarcinoma: A Retrospective Study.

Shi J, Hua X, Zhu B, Ravichandran S, Wang M, Nguyen C, Brodie SA, Palleschi A, Alloisio M, Pariscenti G, Jones K, Zhou W, Bouk AJ, Boland J, Hicks B, Risch A, Bennett H, Luke BT, Song L, Duan J, Liu P, Kohno T, Chen Q, Meerzaman D, Marconett C, Laird-Offringa I, Mills I, Caporaso NE, Gail MH, Pesatori AC, Consonni D, Bertazzi PA, Chanock SJ, Landi MT.

PLoS Med. 2016 Dec 6;13(12):e1002162. doi: 10.1371/journal.pmed.1002162. eCollection 2016 Dec.

33.

Evaluation of Buccal Cell Samples for Studies of Oral Microbiota.

Yu G, Phillips S, Gail MH, Goedert JJ, Humphrys M, Ravel J, Ren Y, Caporaso NE.

Cancer Epidemiol Biomarkers Prev. 2017 Feb;26(2):249-253. doi: 10.1158/1055-9965.EPI-16-0538. Epub 2016 Oct 21.

34.

Characterizing human lung tissue microbiota and its relationship to epidemiological and clinical features.

Yu G, Gail MH, Consonni D, Carugno M, Humphrys M, Pesatori AC, Caporaso NE, Goedert JJ, Ravel J, Landi MT.

Genome Biol. 2016 Jul 28;17(1):163. doi: 10.1186/s13059-016-1021-1.

35.

Breast Cancer Risk From Modifiable and Nonmodifiable Risk Factors Among White Women in the United States.

Maas P, Barrdahl M, Joshi AD, Auer PL, Gaudet MM, Milne RL, Schumacher FR, Anderson WF, Check D, Chattopadhyay S, Baglietto L, Berg CD, Chanock SJ, Cox DG, Figueroa JD, Gail MH, Graubard BI, Haiman CA, Hankinson SE, Hoover RN, Isaacs C, Kolonel LN, Le Marchand L, Lee IM, Lindström S, Overvad K, Romieu I, Sanchez MJ, Southey MC, Stram DO, Tumino R, VanderWeele TJ, Willett WC, Zhang S, Buring JE, Canzian F, Gapstur SM, Henderson BE, Hunter DJ, Giles GG, Prentice RL, Ziegler RG, Kraft P, Garcia-Closas M, Chatterjee N.

JAMA Oncol. 2016 Oct 1;2(10):1295-1302. doi: 10.1001/jamaoncol.2016.1025. Erratum in: JAMA Oncol. 2016 Oct 1;2(10 ):1374.

36.

Endogenous Estrogens, Estrogen Metabolites, and Breast Cancer Risk in Postmenopausal Chinese Women.

Moore SC, Matthews CE, Ou Shu X, Yu K, Gail MH, Xu X, Ji BT, Chow WH, Cai Q, Li H, Yang G, Ruggieri D, Boyd-Morin J, Rothman N, Hoover RN, Gao YT, Zheng W, Ziegler RG.

J Natl Cancer Inst. 2016 May 18;108(10). doi: 10.1093/jnci/djw103. Print 2016 Oct.

37.

Calibration and seasonal adjustment for matched case-control studies of vitamin D and cancer.

Gail MH, Wu J, Wang M, Yaun SS, Cook NR, Eliassen AH, McCullough ML, Yu K, Zeleniuch-Jacquotte A, Smith-Warner SA, Ziegler RG, Carroll RJ.

Stat Med. 2016 Jun 15;35(13):2133-48. doi: 10.1002/sim.6856. Epub 2016 Jan 5.

38.

Associations between cancer and Parkinson's disease in U.S. elderly adults.

Freedman DM, Wu J, Chen H, Engels EA, Enewold LR, Freedman ND, Goedert JJ, Kuncl RW, Gail MH, Pfeiffer RM.

Int J Epidemiol. 2016 Jun;45(3):741-51. doi: 10.1093/ije/dyw016. Epub 2016 Mar 17.

39.

Reply to L.A. Newman.

Park JH, Anderson WF, Gail MH.

J Clin Oncol. 2016 Mar 20;34(9):1014-5. doi: 10.1200/JCO.2015.65.3790. Epub 2016 Jan 19. No abstract available.

40.

Quantifying the Role of Circulating Unconjugated Estradiol in Mediating the Body Mass Index-Breast Cancer Association.

Schairer C, Fuhrman BJ, Boyd-Morin J, Genkinger JM, Gail MH, Hoover RN, Ziegler RG.

Cancer Epidemiol Biomarkers Prev. 2016 Jan;25(1):105-13. doi: 10.1158/1055-9965.EPI-15-0687. Epub 2015 Dec 4.

41.

Is the Benign Breast Disease Breast Cancer Model Well Calibrated?

Gail MH, Pfeiffer RM.

J Clin Oncol. 2015 Sep 1;33(25):2829-30. doi: 10.1200/JCO.2015.61.6177. Epub 2015 Jul 27. No abstract available.

PMID:
26215936
42.

Improvements in US Breast Cancer Survival and Proportion Explained by Tumor Size and Estrogen-Receptor Status.

Park JH, Anderson WF, Gail MH.

J Clin Oncol. 2015 Sep 10;33(26):2870-6. doi: 10.1200/JCO.2014.59.9191. Epub 2015 Jul 20.

43.

Investigation of the association between the fecal microbiota and breast cancer in postmenopausal women: a population-based case-control pilot study.

Goedert JJ, Jones G, Hua X, Xu X, Yu G, Flores R, Falk RT, Gail MH, Shi J, Ravel J, Feigelson HS.

J Natl Cancer Inst. 2015 Jun 1;107(8). pii: djv147. doi: 10.1093/jnci/djv147. Print 2015 Aug.

44.

Are hospitals "keeping up with the Joneses"?: Assessing the spatial and temporal diffusion of the surgical robot.

Li H, Gail MH, Braithwaite RS, Gold HT, Walter D, Liu M, Gross CP, Makarov DV.

Healthc (Amst). 2014 Jul;2(2):152-157.

45.

Lung cancer prognosis before and after recurrence in a population-based setting.

Consonni D, Pierobon M, Gail MH, Rubagotti M, Rotunno M, Goldstein A, Goldin L, Lubin J, Wacholder S, Caporaso NE, Bertazzi PA, Tucker MA, Pesatori AC, Landi MT.

J Natl Cancer Inst. 2015 Mar 23;107(6):djv059. doi: 10.1093/jnci/djv059. Print 2015 Jun.

46.

Beta-diversity metrics of the upper digestive tract microbiome are associated with body mass index.

Lin SW, Freedman ND, Shi J, Gail MH, Vogtmann E, Yu G, Klepac-Ceraj V, Paster BJ, Dye BA, Wang GQ, Wei WQ, Fan JH, Qiao YL, Dawsey SM, Abnet CC.

Obesity (Silver Spring). 2015 Apr;23(4):862-9. doi: 10.1002/oby.21020. Epub 2015 Mar 9.

47.

Twenty-five years of breast cancer risk models and their applications.

Gail MH.

J Natl Cancer Inst. 2015 Feb 26;107(5). pii: djv042. doi: 10.1093/jnci/djv042. Print 2015 May. No abstract available.

48.

Association between tobacco use and the upper gastrointestinal microbiome among Chinese men.

Vogtmann E, Flores R, Yu G, Freedman ND, Shi J, Gail MH, Dye BA, Wang GQ, Klepac-Ceraj V, Paster BJ, Wei WQ, Guo HQ, Dawsey SM, Qiao YL, Abnet CC.

Cancer Causes Control. 2015 Apr;26(4):581-8. doi: 10.1007/s10552-015-0535-2. Epub 2015 Feb 21.

49.

RE: Effects of Helicobacter pylori treatment on gastric cancer incidence and mortality in subgroups. Response.

Gail MH, You WC, Li WQ.

J Natl Cancer Inst. 2014 Nov 7;106(11). pii: dju348. doi: 10.1093/jnci/dju348. Print 2014 Nov. No abstract available.

50.

The association between the upper digestive tract microbiota by HOMIM and oral health in a population-based study in Linxian, China.

Yu G, Dye BA, Gail MH, Shi J, Klepac-Ceraj V, Paster BJ, Wang GQ, Wei WQ, Fan JH, Qiao YL, Dawsey SM, Freedman ND, Abnet CC.

BMC Public Health. 2014 Oct 27;14:1110. doi: 10.1186/1471-2458-14-1110.

Supplemental Content

Support Center